Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid infusion concentration and postoperative nausea/vomiting in lumbar TLIF
ChiCTR2500110642Phase 4Not yet recruiting
- Sponsor
- West China Tianfu Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in lumbosacral disc disease (4 arms), sponsored by West China Tianfu Hospital. Primary endpoint: Incidence and severity of postoperative nausea and vomiting following tranexamic acid infusion administered 6 hours after surgery. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on ChiCTR2500110642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110642.